Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

Similar articles for PubMed (Select 23129632)


Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression.

Luo W, Chang R, Zhong J, Pandey A, Semenza GL.

Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):E3367-76. doi: 10.1073/pnas.1217394109. Epub 2012 Nov 5.


Identification of Jumonji AT-Rich Interactive Domain 1A Inhibitors and Their Effect on Cancer Cells.

Itoh Y, Sawada H, Suzuki M, Tojo T, Sasaki R, Hasegawa M, Mizukami T, Suzuki T.

ACS Med Chem Lett. 2015 Apr 23;6(6):665-70. doi: 10.1021/acsmedchemlett.5b00083. eCollection 2015 Jun 11.


HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells.

Xiang L, Gilkes DM, Hu H, Luo W, Bullen JW, Liang H, Semenza GL.

Oncotarget. 2015 May 20;6(14):11768-78.


Differential HIF-1α and HIF-2α Expression in Mammary Epithelial Cells during Fat Pad Invasion, Lactation, and Involution.

Påhlman S, Lund LR, Jögi A.

PLoS One. 2015 May 8;10(5):e0125771. doi: 10.1371/journal.pone.0125771. eCollection 2015.


Epigenetic regulation by histone demethylases in hypoxia.

Hancock RL, Dunne K, Walport LJ, Flashman E, Kawamura A.

Epigenomics. 2015 Apr 2:1-21. [Epub ahead of print]


Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma.

Li X, Dong S.

Med Oncol. 2015 Mar;32(3):53. doi: 10.1007/s12032-015-0503-4. Epub 2015 Jan 31.


Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype.

Xiang L, Gilkes DM, Hu H, Takano N, Luo W, Lu H, Bullen JW, Samanta D, Liang H, Semenza GL.

Oncotarget. 2014 Dec 30;5(24):12509-27.


Hypoxia-inducible factor 1 and breast cancer metastasis.

Liu ZJ, Semenza GL, Zhang HF.

J Zhejiang Univ Sci B. 2015 Jan;16(1):32-43. doi: 10.1631/jzus.B1400221.


PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxia.

Mudie S, Bandarra D, Batie M, Biddlestone J, Moniz S, Ortmann B, Shmakova A, Rocha S.

Cell Cycle. 2014;13(24):3878-91. doi: 10.4161/15384101.2014.972889.


Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2α.

Guo X, Tian Z, Wang X, Pan S, Huang W, Shen Y, Gui Y, Duan X, Cai Z.

Acta Biochim Biophys Sin (Shanghai). 2015 Feb;47(2):106-13. doi: 10.1093/abbs/gmu122. Epub 2014 Dec 17.


TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator.

Tsai YP, Chen HF, Chen SY, Cheng WC, Wang HW, Shen ZJ, Song C, Teng SC, He C, Wu KJ.

Genome Biol. 2014 Dec 3;15(12):513. doi: 10.1186/s13059-014-0513-0.


The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.

Wade MA, Jones D, Wilson L, Stockley J, Coffey K, Robson CN, Gaughan L.

Nucleic Acids Res. 2015 Jan;43(1):196-207. doi: 10.1093/nar/gku1298. Epub 2014 Dec 8.


Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells.

Samanta D, Gilkes DM, Chaturvedi P, Xiang L, Semenza GL.

Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5429-38. doi: 10.1073/pnas.1421438111. Epub 2014 Dec 1.


[A novel HIF-1 inhibitor--manassantin A derivative LXY6099 inhibits tumor growth].

Lai FF, Liu XY, Niu F, Lang LW, Xie P, Chen XG.

Yao Xue Xue Bao. 2014 May;49(5):622-6. Chinese.


The hypoxia-inducible epigenetic regulators Jmjd1a and G9a provide a mechanistic link between angiogenesis and tumor growth.

Ueda J, Ho JC, Lee KL, Kitajima S, Yang H, Sun W, Fukuhara N, Zaiden N, Chan SL, Tachibana M, Shinkai Y, Kato H, Poellinger L.

Mol Cell Biol. 2014 Oct 1;34(19):3702-20. doi: 10.1128/MCB.00099-14. Epub 2014 Jul 28.


A new method to assay hypoxia-inducible factor-1 based on small molecule binding DNA.

Yang N, Li H, Yin T, Huang Y, Sun L, Li G.

Anal Chim Acta. 2014 Aug 1;838:31-6. doi: 10.1016/j.aca.2014.05.045. Epub 2014 May 29.


Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells.

Rizwani W, Schaal C, Kunigal S, Coppola D, Chellappan S.

PLoS One. 2014 Jul 16;9(7):e100888. doi: 10.1371/journal.pone.0100888. eCollection 2014.


A polymorphism in JMJD2C alters the cleavage by caspase-3 and the prognosis of human breast cancer.

Hong Q, Yu S, Yang Y, Liu G, Shao Z.

Oncotarget. 2014 Jul 15;5(13):4779-87.


Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors.

Kim TD, Fuchs JR, Schwartz E, Abdelhamid D, Etter J, Berry WL, Li C, Ihnat MA, Li PK, Janknecht R.

Am J Transl Res. 2014 May 15;6(3):236-47. eCollection 2014.


Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment.

Chaturvedi P, Gilkes DM, Takano N, Semenza GL.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):E2120-9. doi: 10.1073/pnas.1406655111. Epub 2014 May 5.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk